- Director of Education Initiatives
Berman Institute of Bioethics
Dept. of Pediatrics, Johns Hopkins School of Medicine
Departments of Health, Behavior & Society and Health Policy & Management
Johns Hopkins Bloomberg School of Public Health
Gail Geller, ScD, MHS, is the Berman Institute’s Director of Education Initiatives and a Professor in the Department of Medicine, with joint appointments in the Department of Pediatrics and the Bloomberg School of Public Health’s Departments of Health, Behavior & Society and Health Policy & Management. Dr. Geller has been an active member of the ELSI (Ethical, Legal & Social Implications of Genetics) research community since its inception. For over 25 years, she has conducted empirical research – both quantitative and qualitative – on the ethical and social implications of genetic testing in the adult, pediatric and family contexts. Currently, she is Co-Principal Investigator of an NHGRI CEER (Center of Excellence in ELSI Research) designed to address the ELSI issues arising from the application of genomics to the prevention and treatment of infectious diseases. She has been a member of two NIH Consortia: the Cancer Genetics Studies Consortium and the Informed Consent Consortium, and co-chaired the Task Force on Informed Consent for Cancer Susceptibility Testing.
In addition to her work in genetics, she has longstanding interests in the areas of medical socialization, provider-patient communication under conditions of uncertainty, and cultural differences in attitudes toward health and disease. These themes are reflected in Dr. Geller’s other substantive areas of scholarship: the use of complementary and alternative medicine (CAM), and the role of palliative care in chronic diseases. She received one of the highly coveted NIH “challenge” grants to explore the integration of palliative care in the management of children, young adults and families affected by chronic, life-threatening disorders (muscular dystrophy and sickle cell disease). She received a prestigious Kornfeld Fellowship to explore the intersection of bioethics and CAM. She has served as co-director of the educational component of the Johns Hopkins CAM Center, ethics representative on the Data Safety & Monitoring Board of the National Center for Complementary & Alternative Medicine (NCCAM), and adjunct faculty at the Tai Sophia Institute in their Master’s Program in Transformative Leadership and Social Change.
Dr. Geller also has longstanding interests in ethics education. She served as Co-Deputy Director of the Greenwall Fellowship Program in Bioethics & Health Policy until 2012, and now as the Berman Institute’s Director of Education Initiatives oversees the Hecht-Levi Fellowship Program in Bioethics, the Masters in Bioethics and the Bioethics Intensives.
As Co-director of a Fogarty International Center training grant in China, Dr. Geller taught young Chinese geneticists about the social, psychological, cultural and ethical components of their research. She currently oversees the “social and behavioral” Horizontal Strands in the medical curriculum at Johns Hopkins, which include ethics and professionalism. In addition, she co-directs two courses in the School of Medicine: (1) the Scholarly Concentration called Ethics and the ‘Art’ of Medicine; and (2) Integrative Medicine.
In 1991, through a Chateaubriand Fellowship from the French Ministry of Foreign Affairs, Dr. Geller was a visiting scientist in Paris where she studied obstetricians’ attitudes toward fetal anomaly. She has since served on the Board of Directors of the American Society for Bioethics & Humanities, the scientific review panel for the ELSI Program (Ethical, Legal and Social Issues) at NIH’s National Human Genome Research Institute, the Advisory Board of the Center for Genetics Research Ethics and Law (CGREAL) at Case Western Reserve University, and the IOM Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials. She was a Consultant to the Ethics Working Group of the National Children’s Study, the Informed Consent Working Group of the Secretary’s Advisory Committee on Genetic Testing (SACGT), the CDC’s Program in Public Health Genetics, and the Presidential Advisory Committee on Human Radiation Experiments. She is a Fellow of the Hastings Center.
- Quantitative and qualitative empirical research on the ethical and social implications of genetic testing in the adult, pediatric and family context
- Ethical issues arising from the application of genomics to the prevention and treatment of infectious diseases
- BS, Cornell University
- ScD, Johns Hopkins Bloomberg School of Public Health
- MHS, Johns Hopkins Bloomberg School of Public Health
Carrese JA, Geller G, Branyon ED, Forbes LK, Topazian RJ, Weir BW, Khatib O, Sugarman J. A Direct Observation Checklist to Measure Respect and Dignity in the Intensive Care Unit. Crit Care Med (in press).
Geller G, Branyon ED, Forbes LK, Topazian RJ, Weir BW, Carrese JA, Beach MC, Sugarman J. ICU-RESPECT: An Index to Assess Patient and Family Experiences of Respect in the Intensive Care Unit. J Crit Care (in press)
Geller G, Branyon E, Forbes L, Rushton C, Beach MC, Carrese J, Sugarman J. Health care professionals’ perceptions and experiences of respect and dignity in the intensive care unit. Narrative Inquiry in Bioethics, 2015; 5(1A): 27–42.
Geller, G., Dvoskin, R., Thio, C. L., Duggal, P., Lewis, M. H., Bailey, T. C., … & Kahn, J. P. (2014). Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice. Genome Medicine 11, 18.
Geller, G., Harrison, K. L., & Rushton, C. H. (2013). Ethical challenges in the care of children and families affected by life-limiting neuromuscular diseases. Journal of Developmental & Behavioral Pediatrics, 33(7), 548-561.
Geller, G. (2013). Tolerance for ambiguity: an ethics-based criterion for medical student selection. Academic Medicine, 88(5), 581-584.
Rushton, C. H., Erby, L. H., Cohn, R. D., & Geller, G. (2012). Integrating Palliative Care in Life-Limiting Pediatric Neuromuscular Conditions: The Case of SMA-Type 1 and Duchene Muscular Dystrophy. J Palliative Care Med,2(103), 2.
Harrison, K. L., Geller, G., Marshall, P., Tilburt, J., Mercer, M. B., Brinich, M. A., … & Sharp, R. R. (2012). Ethical discourse about the modification of food for therapeutic purposes: How patients with gastrointestinal diseases view the good, the bad, and the healthy. AJOB primary research, 3(3), 12-20.
McCormick, J. B., Hammer, R. R., Farrell, R. M., Geller, G., James, K. M., Loftus Jr, E. V., … & Sharp, R. R. (2012). Experiences of patients with chronic gastrointestinal conditions: in their own words. Health and quality of life outcomes, 10(1), 1-11.
Geller, G., Boyce, A., Ford, D. E., & Sugarman, J. (2010). Beyond “compliance”: The role of institutional culture in promoting research integrity. Academic Medicine, 85(8), 1296-1302.
Bernhardt, B. A., Silver, R., Rushton, C. H., Micco, E., & Geller, G. (2010). What keeps you up at night? genetics professionals’ distressing experiences in patient care. Genetics in Medicine, 12(5), 289-297.